Astera Labs (NASDAQ:ALAB) Shares Gap Down Following Analyst Downgrade

Key Points

• Astera Labs shares fell after Susquehanna cut its price target from $310 to $258 and maintained a neutral rating. Shares opened at $217.97, down from the prior close of $233.62.
• The company reported Q3 earnings of $1.32 per share and revenue of $584.9 million, beating analyst estimates; revenue grew 154% year over year, and its outlook also topped expectations.
• Analyst views remain broadly positive: Northland upgraded the stock to outperform, and the consensus rating is Moderate Buy with a $324.37 price target.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares gapped down before the market opened on Wednesday after Susquehanna lowered their price target on the stock from $310.00 to $258.00. The stock had previously closed at $233.62, but opened at $217.97. Susquehanna currently has a neutral rating on the stock. Astera Labs shares last traded at $226.2720, with a volume of 1,677,585 shares changing hands.

A number of other equities analysts have also recently issued reports on ALAB. Northland Securities upgraded shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research report on Wednesday. Royal Bank Of Canada increased their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research note on Monday, July 20th. TD Cowen reduced their price target on Astera Labs from $375.00 to $300.00 and set a "hold" rating on the stock in a report on Monday, October 19th. Finally, Roth Capital reaffirmed a "buy" rating and set a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Twelve research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $324.37.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the business's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company's stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the completion of the transaction, the director owned 3,309 shares of the company's stock, valued at $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by corporate insiders.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported Q3 earnings of $1.32 per share, above the $1.19 consensus, and revenue of $584.9 million, beating estimates of $550.78 million. Revenue rose 154% year over year and 49% sequentially. The company also said its outlook topped estimates. Astera Labs Q3 results
• Positive Sentiment: Scorpio fabric switches became Astera Labs’ largest product family, led by volume production of the Scorpio X-Series 320-lane switch, signaling strong demand for its AI-infrastructure connectivity products. Astera Labs Q3 results
• Positive Sentiment: Northland Securities upgraded ALAB from “market perform” to “outperform” and set a $315 price target, indicating confidence in further upside. Northland Securities recommendations
• Negative Sentiment: Susquehanna lowered its price target from $310 to $258 and maintained a “neutral” rating. Although the new target remains above the cited share price, the reduction suggests a more cautious view. Susquehanna recommendations
• Negative Sentiment: Recent selling pressure and a break below the 200-day moving average point to technical weakness that could temper the response to the earnings beat. Astera Labs technical analysis

Institutional Trading of Astera Labs

Large investors have recently bought and sold shares of the company. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs in the second quarter valued at approximately $25,000. Archer Investment Corp purchased a new stake in shares of Astera Labs during the second quarter valued at approximately $30,000. Transamerica Financial Advisors LLC acquired a new position in shares of Astera Labs during the second quarter worth $35,000. Continuum Advisory LLC acquired a new position in shares of Astera Labs during the second quarter worth $37,000. Finally, GK Wealth Management LLC purchased a new position in shares of Astera Labs in the third quarter valued at $29,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Down 4.4%

The firm has a market capitalization of $38.73 billion, a PE ratio of 111.27 and a beta of 3.85. The firm's 50 day moving average price is $306.13 and its two-hundred day moving average price is $255.53.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm's quarterly revenue was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.